{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:37:21Z","timestamp":1791859041896,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"DOI":"10.1186\/s42238-025-00333-4","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:25:55Z","timestamp":1759173955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ABCB1 polymorphisms are associated with clinical response to nabiximols in patients with multiple sclerosis-related spasticity"],"prefix":"10.1186","volume":"7","author":[{"given":"Alessandra","family":"Gemma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Versino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alen","family":"Zollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Martinelli","family":"Boneschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"333_CR1","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ejp.1605","volume":"24","author":"S Almog","year":"2020","unstructured":"Almog S, Aharon-Peretz J, Vulfsons S, Ogintz M, Abalia H, Lupo T, Hayon Y, Eisenberg E. The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: a randomized, double-blinded, placebo-controlled trial. Eur J Pain. 2020;24:1505\u201316. https:\/\/doi.org\/10.1002\/ejp.1605","journal-title":"Eur J Pain"},{"key":"333_CR2","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.3390\/cimb45040228","volume":"45","author":"M Babayeva","year":"2023","unstructured":"Babayeva M, Loewy ZG. Cannabis pharmacogenomics: a path to personalized medicine. Curr Issues Mol Biol. 2023;45:3479\u2013514. https:\/\/doi.org\/10.3390\/cimb45040228","journal-title":"Curr Issues Mol Biol"},{"key":"333_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/ph16050645","volume":"16","author":"A Batinic","year":"2023","unstructured":"Batinic A, Sutlovi\u0107 D, Kuret S, Matana A, Kumric M, Bozic J, Dujic Z. Trial of a novel oral cannabinoid formulation in patients with hypertension: a double-blind, placebo-controlled pharmacogenetic study. Pharmaceuticals (Basel). 2023;16:645. https:\/\/doi.org\/10.3390\/ph16050645","journal-title":"Pharmaceuticals (Basel)"},{"key":"333_CR4","first-page":"445","volume":"65","author":"AJ Brambila-Tapia","year":"2013","unstructured":"Brambila-Tapia AJ. MDR1 (ABCB1) polymorphisms: functional effects and clinical implications. Rev Investig Clin. 2013;65:445\u201354.","journal-title":"Rev Investig Clin"},{"issue":"3","key":"333_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2217\/nmt-2022-0002","volume":"12","author":"A Chan","year":"2022","unstructured":"Chan A, Silv\u00e1n CV. Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap. Neurodegener Dis Manag. 2022;12(3):141\u201354. https:\/\/doi.org\/10.2217\/nmt-2022-0002","journal-title":"Neurodegener Dis Manag"},{"issue":"3","key":"333_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1198\/sbr.2009.08076","volume":"2","author":"Chi-hong Tseng & Yongzhao Shao","year":"2010","unstructured":"Chi-hong Tseng & Yongzhao Shao. Sample size analysis for pharmacogenetic studies. Stat Biopharm Res. 2010;2(3):319\u201328. https:\/\/doi.org\/10.1198\/sbr.2009.08076","journal-title":"Stat Biopharm Res"},{"key":"333_CR7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1089\/gtmb.2012.0244","volume":"16","author":"N Col Araz","year":"2012","unstructured":"Col Araz N, Nacak M, Oguzkan Balci S, Benlier N, Araz M, Pehlivan S, Balat A, Aynacioglu AS. Childhood obesity and the role of dopamine D2 receptor and cannabinoid receptor-1 gene polymorphisms. Genet Test Mol Biomarkers. 2012;16:1408\u201312. https:\/\/doi.org\/10.1089\/gtmb.2012.0244","journal-title":"Genet Test Mol Biomarkers"},{"key":"333_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/ijms18020242","volume":"18","author":"C Comi","year":"2017","unstructured":"Comi C, Ferrari M, Marino F, Magistrelli L, Cantello R, Riboldazzi G, Bianchi ML, Bono G, Cosentino M. Polymor-phisms of dopamine receptor genes and risk of L-Dopa-induced dyskinesia in Parkinson\u2019s disease. Int J Mol Sci. 2017;18:242. https:\/\/doi.org\/10.3390\/ijms18020242","journal-title":"Int J Mol Sci"},{"key":"333_CR9","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/cpt.2408","volume":"110","author":"BH Davis","year":"2021","unstructured":"Davis BH, Beasley TM, Amaral M, Szaflarski JP, Gaston T, Perry Grayson L, Standaert DG, Bebin EM, Limdi NA, UAB CBD Study Group (includes all the investigators involved in the UAB EAP CBD program). Pharmacogenetic predictors of cannabidiol response and tolerability in treatment-resistant epilepsy. Clin Pharmacol Ther. 2021a;110:1368\u201380. https:\/\/doi.org\/10.1002\/cpt.2408","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"333_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11481-009-9177-z","volume":"5","author":"L De Petrocellis","year":"2010","unstructured":"De Petrocellis L, Di Marzo V. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J Neuroimmune Pharmacol. 2010;5(1):103\u201321. https:\/\/doi.org\/10.1007\/s11481-009-9177-z","journal-title":"J Neuroimmune Pharmacol"},{"key":"333_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","volume":"113","author":"RH Dworkin","year":"2005","unstructured":"Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113:9\u201319. https:\/\/doi.org\/10.1016\/j.pain.2004.09.012","journal-title":"Pain"},{"key":"333_CR12","unstructured":"eMC. Sativex oromucosal spray. SmPc. 2022."},{"key":"333_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/ACO.0b013e3283556228","volume":"25","author":"CR Fernandez Robles","year":"2012","unstructured":"Fernandez Robles CR, Degnan M, Candiotti KA. Pain and genetics. Curr Opin Anaesthesiol. 2012;25:444\u20139. https:\/\/doi.org\/10.1097\/ACO.0b013e3283556228","journal-title":"Curr Opin Anaesthesiol"},{"key":"333_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00228-016-2111-4","volume":"72","author":"M Ferrari","year":"2016","unstructured":"Ferrari M, Comi C, Marino F, Magistrelli L, De Marchi F, Cantello R, Riboldazzi G, Bono G, Cosentino M. Polymor-phisms of dopamine receptor genes and risk of visual hallucinations in parkinson\u2019s patients. Eur J Clin Pharmacol. 2016;72:1335\u201341. https:\/\/doi.org\/10.1007\/s00228-016-2111-4","journal-title":"Eur J Clin Pharmacol"},{"key":"333_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/genes15060736","volume":"15","author":"M Ferrari","year":"2024","unstructured":"Ferrari M, Vecchio D, D\u2019Alfonso S, Gemma A, Marino F, Comi C, Cosentino M. Polymorphisms in the dopaminergic receptor D3 gene correlate with disease progression rate in relapsing-remitting multiple sclerosis patients. Genes (Basel). 2024;15:736. https:\/\/doi.org\/10.3390\/genes15060736","journal-title":"Genes (Basel)"},{"key":"333_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10072-015-2392-x","volume":"37","author":"L Ferr\u00e8","year":"2016","unstructured":"Ferr\u00e8 L, Nuara A, Pavan G, Radaelli M, Moiola L, Rodegher M, Colombo B, Keller Sarmiento IJ, Martinelli V, Leocani L, Martinelli Boneschi F, Comi G, Esposito F. Efficacy and safety of nabiximols (Sativex(\u00ae)) on multiple sclerosis spasticity in a real-life Italian monocentric study. Neurol Sci. 2016;37:235\u201342. https:\/\/doi.org\/10.1007\/s10072-015-2392-x","journal-title":"Neurol Sci"},{"key":"333_CR17","doi-asserted-by":"publisher","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA. Multiple sclerosis. Nat Rev Dis Primers. 2018;4(1):43. https:\/\/doi.org\/10.1038\/s41572-018-0041-4. Erratum in: Nat Rev Dis Primers. 2018;4:49. https:\/\/doi.org\/10.1038\/s41572-018-0050-3.","DOI":"10.1038\/s41572-018-0041-4"},{"issue":"2","key":"333_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11481-021-09982-7","volume":"16","author":"A Furgiuele","year":"2021","unstructured":"Furgiuele A, Cosentino M, Ferrari M, Marino F. Immunomodulatory potential of cannabidiol in multiple sclerosis: a systematic review. J Neuroimmune Pharmacol. 2021;16(2):251\u201369. https:\/\/doi.org\/10.1007\/s11481-021-09982-7","journal-title":"J Neuroimmune Pharmacol"},{"key":"333_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1073\/pnas.97.7.3473","volume":"28","author":"S Hoffmeyer","year":"2000","unstructured":"Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockm\u00f6ller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000;28:97. https:\/\/doi.org\/10.1073\/pnas.97.7.3473","journal-title":"Proc Natl Acad Sci U S A"},{"key":"333_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13318-017-0416-z","volume":"43","author":"S Hryhorowicz","year":"2018","unstructured":"Hryhorowicz S, Walczak M, Zakerska-Banaszak O, S\u0142omski R, Skrzypczak-Zieli\u0144ska M. Pharmacogenetics of cannabinoids. Eur J Drug Metab Pharmacokinet. 2018;43:1\u201312. https:\/\/doi.org\/10.1007\/s13318-017-0416-z","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"333_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/sj.tpj.6500431","volume":"7","author":"H Ishiguro","year":"2007","unstructured":"Ishiguro H, Iwasaki S, Teasenfitz L, Higuchi S, Horiuchi Y, Saito T, Arinami T, Onaivi ES. Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenomics J. 2007;7:380\u20135. https:\/\/doi.org\/10.1038\/sj.tpj.6500431","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"333_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/IJPC.IJPC_155_19","volume":"26","author":"A Jose","year":"2020","unstructured":"Jose A, Thomas L, Baburaj G, Munisamy M, Rao M. Cannabinoids as an alternative option for conventional analgesics in cancer pain management: a pharmacogenomics perspective. Indian J Palliat Care. 2020;26(1):129\u201333. https:\/\/doi.org\/10.4103\/IJPC.IJPC_155_19","journal-title":"Indian J Palliat Care"},{"issue":"5","key":"333_CR23","doi-asserted-by":"publisher","first-page":"e1001863","DOI":"10.1371\/journal.pbio.1001863","volume":"12","author":"J Kimmelman","year":"2014","unstructured":"Kimmelman J, Mogil JS, Dirnagl U. Distinguishing between exploratory and confirmatory preclinical research will improve translation. PLoS Biol. 2014;12(5):e1001863. https:\/\/doi.org\/10.1371\/journal.pbio.1001863","journal-title":"PLoS Biol"},{"key":"333_CR24","doi-asserted-by":"publisher","unstructured":"Kister I, Bacon TE, Chamot E, Salter AR, Cutter GR, Kalina JT, Herbert J. Natural history of multiple sclerosis symptoms. Int J MS Care. 15(2013) 146\u201358. https:\/\/doi.org\/10.7224\/1537-2073.2012-053. Erratum in: Int J MS Care. 2014;4(16):170. https:\/\/doi.org\/10.7224\/1537-2073-16.4.170","DOI":"10.7224\/1537-2073.2012-053"},{"key":"333_CR25","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.3390\/molecules28062791","volume":"28","author":"S Kitdumrongthum","year":"2023","unstructured":"Kitdumrongthum S, Trachootham D. An individuality of response to cannabinoids: challenges in safety and efficacy of cannabis products. Molecules. 2023;28:2791. https:\/\/doi.org\/10.3390\/molecules28062791","journal-title":"Molecules"},{"issue":"12","key":"333_CR26","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.2174\/1570159X21666230727094431","volume":"21","author":"D Kleiner","year":"2023","unstructured":"Kleiner D, Horv\u00e1th IL, Bunduc S, Gerg\u0151 D, Lugosi K, Feh\u00e9rv\u00e1ri P, Hegyi P, Csupor D. Nabiximols is efficient as add-on treatment for patients with multiple sclerosis spasticity refractory to standard treatment: a systematic review and meta-analysis of randomised clinical trials. Curr Neuropharmacol. 2023;21(12):2505\u201315. https:\/\/doi.org\/10.2174\/1570159X21666230727094431","journal-title":"Curr Neuropharmacol"},{"key":"333_CR27","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.3390\/ijms24043125","volume":"24","author":"S Martini","year":"2023","unstructured":"Martini S, Gemma A, Ferrari M, Cosentino M, Marino F. Effects of cannabidiol on innate immunity: experimental evidence and clinical relevance. Int J Mol Sci. 2023;24:3125. https:\/\/doi.org\/10.3390\/ijms24043125","journal-title":"Int J Mol Sci"},{"key":"333_CR28","doi-asserted-by":"publisher","first-page":"e93771","DOI":"10.1371\/journal.pone.0093771","volume":"9","author":"M Matsunaga","year":"2014","unstructured":"Matsunaga M, Isowa T, Yamakawa K, Fukuyama S, Shinoda J, Yamada J, Ohira H. Genetic variations in the human cannabinoid receptor gene are associated with happiness. PLoS ONE. 2014;9:e93771. https:\/\/doi.org\/10.1371\/journal.pone.0093771","journal-title":"PLoS ONE"},{"key":"333_CR29","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1177\/0269881112454229","volume":"26","author":"M Mitjans","year":"2012","unstructured":"Mitjans M, Gast\u00f3 C, Catal\u00e1n R, Fa\u00f1an\u00e1s L, Arias B. Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes. J Psychopharmacol. 2012;26:1391\u20138. https:\/\/doi.org\/10.1177\/0269881112454229","journal-title":"J Psychopharmacol"},{"key":"333_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.20517\/jtgg.2020.52","volume":"5","author":"A Owusu Obeng","year":"2021","unstructured":"Owusu Obeng A, El Rouby N, Liu M, Wallsten R. Important preparatory steps and clinical considerations for pharmacogenetics adoption into practice. J Transl Genet Genom. 2021;5:64\u201379. https:\/\/doi.org\/10.20517\/jtgg.2020.52","journal-title":"J Transl Genet Genom"},{"key":"333_CR31","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3390\/genes13101832","volume":"13","author":"P Poli","year":"2022","unstructured":"Poli P, Peruzzi L, Maurizi P, Mencucci A, Scocca A, Carnevale S, Spiga O, Santucci A. The pharmacogenetics of cannabis in the treatment of chronic pain. Genes (Basel). 2022;13:1832. https:\/\/doi.org\/10.3390\/genes13101832","journal-title":"Genes (Basel)"},{"key":"333_CR32","doi-asserted-by":"publisher","first-page":"E515","DOI":"10.1208\/aapsj080361","volume":"8","author":"D Wang","year":"2006","unstructured":"Wang D, Sad\u00e9e W. Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1). AAPS J. 2006;8:E515\u201320. https:\/\/doi.org\/10.1208\/aapsj080361","journal-title":"AAPS J"},{"key":"333_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s13318-019-00559-7","volume":"44","author":"WR Wolowich","year":"2019","unstructured":"Wolowich WR, Greif R, Kleine-Brueggeney M, Bernhard W, Theiler L. Minimal physiologically based pharmacokinetic model of intravenously and orally administered delta-9-tetrahydrocannabinol in healthy volunteers. Eur J Drug Metab Pharmacokinet. 2019;44:691\u2013711. https:\/\/doi.org\/10.1007\/s13318-019-00559-7","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"333_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2982.2011.01874.x","volume":"24","author":"BS Wong","year":"2012","unstructured":"Wong BS, Camilleri M, Eckert D, Carlson P, Ryks M, Burton D, Zinsmeister AR. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterol Motil. 2012;24:358\u2013e169. https:\/\/doi.org\/10.1111\/j.1365-2982.2011.01874.x","journal-title":"Neurogastroenterol Motil"},{"key":"333_CR35","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00216-008-2291-6","volume":"392","author":"UM Zanger","year":"2008","unstructured":"Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics\/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 2008;392:1093\u2013108. https:\/\/doi.org\/10.1007\/s00216-008-2291-6","journal-title":"Anal Bioanal Chem"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00333-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-025-00333-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00333-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:25:56Z","timestamp":1759173956000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcannabisresearch.biomedcentral.com\/articles\/10.1186\/s42238-025-00333-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1186\/s42238-025-00333-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7008522\/v1","asserted-by":"object"}]},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee (ASST Sette Laghi Hospital, Varese, Italy on February 21, 2023 - Study number 164) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Authors wish to dedicate this study to the loving memory of Paola Banfi, dearest friend, caring physician, and invaluable scientist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Additional information"}}],"article-number":"72"}}